Dr. Adler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2022 Brookwood Medical Ctr Dr
Acc G-105
Birmingham, AL 35209Phone+1 205-877-2888Fax+1 205-877-2039
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1991
- University of MichiganResidency, Internal Medicine, 1982 - 1985
- Boston University School of MedicineClass of 1982
Certifications & Licensure
- AL State Medical License 1988 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 338 citationsThe risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-upMartin H. Steinberg, William F. McCarthy, Oswaldo Castro, Samir K. Ballas, F. Danny Armstrong
American Journal of Hematology. 2010-06-01 - 116 citationsInfluence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.Nita A. Limdi, Donna K. Arnett, Joyce A. Goldstein, T. Mark Beasley, Gerald McGwin
Pharmacogenomics. 2008-05-09 - 189 citationsInfluence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.Nita A. Limdi, Gerald McGwin, Joyce A. Goldstein, T. Beasley, Donna K. Arnett
Clinical Pharmacology and Therapeutics. 2008-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: